Hepatitis in dogs

  • Jan Rothuizen
Part of the Birkhäuser Advances in Infectious Diseases book series (BAID)


Liver diseases are a major focus of research in the Faculty of Veterinary Medicine. In a clinical population 1% of the dogs has a form of hepatitis. There are several aspects of canine hepatitis which make comparison with human hepatitis very useful. As a whole, liver diseases and especially different forms of hepatitis in dogs develop highly similar to human hepatitis (fulminant, acute, chronic). This makes dog diseases interesting to study important aspects in the pathogenesis of the disease. We have shown that in humans and dogs identical processes with respect to formation of fibrosis, regeneration, stem cell activation, and oxidative damage occur. In most aspects identical pathogenesis and pathophysiology of canine and human hepatitis make these spontaneous dog diseases ideal models to study the effect of new modes of intervention to stimulate regeneration and reduce or prevent cirrhosis.


Hepatic Encephalopathy Intrahepatic Cholestasis Human Hepatitis Drug Induce Hepatitis Liver Cell Necrosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rothuizen J, Bunch SE, Charles JA, Cullen JM, Desmet VJ, Szatmari V, Twedt DC, van den Ingh TSGAM, van Winkle TJ, Washabau RJ, WSAVA Liver Standardization Group (2006) WSAVA Standards for Clinical and Histological Diagnosis of Canine and Feline Liver Disease. Saunders-Elsevier, EdinburghGoogle Scholar
  2. 2.
    Decaro N, Campolo M, Elia G, Buonavoglia D, Colaianni ML, Lorusso A, Mari V, Buonavoglia C (2007) Infectious canine hepatitis: an “old” disease reemerging in Italy. Res Vet Sci 83: 269–273PubMedCrossRefGoogle Scholar
  3. 3.
    Solleveld HA, van Zwieten MJ, van Kessel AC, Heidt PJ (1978) Nalidixic acid intoxication in two pregnant bitches. Tijdschr Diergeneeskd 103: 899–906PubMedGoogle Scholar
  4. 4.
    Duffell SJ (1975) Letter: Unexpected reaction to nalidixic acid. Vet Rec 96: 188PubMedGoogle Scholar
  5. 5.
    Trepanier LA (2004) Idiosyncratic toxicity associated with potentiated sulfonamides in the dog. J Vet Pharmacol Ther 27: 129–138PubMedCrossRefGoogle Scholar
  6. 6.
    Twedt DC, Diehl KJ, Lappin MR, Getzy DM (1997) Association of hepatic necrosis with trimethoprim sulfonamide administration in 4 dogs. J Vet Intern Med 11: 20–23PubMedGoogle Scholar
  7. 7.
    Ghneim GS, Viers JH, Chomel BB, Kass PH, Descollonges DA, Johnson ML (2007) Use of a case-control study and geographic information systems to determine environmental and demographic risk factors for canine leptospirosis. Vet Res 38: 37–50PubMedCrossRefGoogle Scholar
  8. 8.
    Moore GE, Guptill LF, Glickman NW, Caldanaro RJ, Aucoin D, Glickman LT (2006) Canine leptospirosis, United States, 2002–2004. Emerg Infect Dis 12: 501–503PubMedGoogle Scholar
  9. 9.
    Greenlee JJ, Alt DP, Bolin CA, Zuerner RL, Andreasen CB (2005) Experimental canine leptospirosis caused by Leptospira interrogans serovars pomona and bratislava. Am J Vet Res 66: 1816–1822PubMedCrossRefGoogle Scholar
  10. 10.
    Faucher JF, Hoen B, Estavoyer JM (2004) The management of leptospirosis. Expert Opin Pharmacother 5: 819–827PubMedCrossRefGoogle Scholar
  11. 11.
    Shih JL, Keating JH, Freeman LM, Webster CR (2007) Chronic hepatitis in Labrador Retrievers: clinical presentation and prognostic factors. J Vet Intern Med 21: 33–39PubMedCrossRefGoogle Scholar
  12. 12.
    Watson PJ (2004) Chronic hepatitis in dogs: a review of current understanding of the aetiology, progression, and treatment. Vet J 167: 228–241PubMedCrossRefGoogle Scholar
  13. 13.
    Rothuizen J (2004) Canine chronic liver disease: where are we now? Four pointers for future research. Vet J 167: 219PubMedCrossRefGoogle Scholar
  14. 14.
    Boisclair J, Dore M, Beauchamp G, Chouinard L, Girard C (2001) Characterization of the inflammatory infiltrate in canine chronic hepatitis. Vet Pathol 38: 628–635PubMedCrossRefGoogle Scholar
  15. 15.
    Vitral CL, Pinto MA, Lewis-Ximenez LL, Khudyakov YE, dos Santos DR, Gaspar AM (2005) Serological evidence of hepatitis E virus infection in different animal species from the Southeast of Brazil. Mem Inst Oswaldo Cruz 100: 117–122PubMedCrossRefGoogle Scholar
  16. 16.
    Boomkens SY, Slump E, Egberink HF, Rothuizen J, Penning LC (2005) PCR screening for candidate etiological agents of canine hepatitis. Vet Microbiol 108: 49–55PubMedCrossRefGoogle Scholar
  17. 17.
    Boomkens SY, Penning LC, Egberink HF, van den Ingh TS, Rothuizen J (2004) Hepatitis with special reference to dogs. A review on the pathogenesis and infectious etiologies, including unpublished results of recent own studies. Vet Q 26: 107–114PubMedGoogle Scholar
  18. 18.
    Morris TQ, Gocke DJ (1972) Modified acute canine viral hepatitis-a model for physiologic study. Proc Soc Exp Biol Med 139: 32–39PubMedGoogle Scholar
  19. 19.
    Gocke DJ, Preisig R, Morris TQ, McKay DG, Bradley SE (1967) Experimental viral hepatitis in the dog: production of persistent disease in partially immune animals. J Clin Invest 46: 1506–1517PubMedGoogle Scholar
  20. 20.
    Rolfe, Twedt (1995) Copper-associated hepatopathies in dogs. Vet Clin N Am Small Animal Practice 2: 399–417Google Scholar
  21. 21.
    Hoffmann G, van den Ingh TS, Bode P, Rothuizen J (2006) Copper-associated chronic hepatitis in Labrador Retrievers. J Vet Intern Med 20: 856–861PubMedCrossRefGoogle Scholar
  22. 22.
    Mandigers, van den Ingh, Bode, Teske E, Rothuizen J (2004) Association between liver copper concentration and subclinical hepatitis in Doberman Pinschers. J Vet Internal Med 18: 647–650CrossRefGoogle Scholar
  23. 23.
    Speeti, Eriksson, Saari, Westermarck (1998) Lesions of subclinical doberman hepatitis. Vet Pathology 35: 361–369CrossRefGoogle Scholar
  24. 24.
    Spee B, Arends B, van den Ingh TS, Penning LC, Rothuizen J (2006) Copper metabolism and oxidative stress in chronic inflammatory and cholestatic liver diseases in dogs. J Vet Intern Med 20: 1085–1092PubMedCrossRefGoogle Scholar
  25. 25.
    Mandigers PJ, Bode P, van Wees AM, van den Brom WE, van den Ingh TS, Rothuizen J (2007) Hepatic (64)Cu excretion in Dobermanns with subclinical hepatitis. Res Vet Sci 83: 204–209PubMedCrossRefGoogle Scholar
  26. 26.
    Mandigers PJ, van den Ingh TS, Bode P, Rothuizen J (2005) Improvement in liver pathology after 4 months of D-penicillamine in 5 doberman pinschers with subclinical hepatitis. J Vet Intern Med 19: 40–43PubMedCrossRefGoogle Scholar
  27. 27.
    Spee B, Arends B, van Wees AM, Bode P, Penning LC, Rothuizen J (2007) Functional consequences of RNA interference targeting COMMD1 in a canine hepatic cell line in relation to copper toxicosis. Anim Genet 38: 168–170PubMedCrossRefGoogle Scholar
  28. 28.
    Favier RP, Spee B, Penning LC, Brinkhof B, Rothuizen J (2005) Quantitative PCR method to detect a 13-kb deletion in the MURR1 gene associated with copper toxicosis and HIV-1 replication. Mamm Genome 16: 460–463PubMedCrossRefGoogle Scholar
  29. 29.
    Haywood S, Rutgers HC, Christian MK (1988) Hepatitis and copper accumulation in Skye terriers. Vet Pathology 25: 408–414CrossRefGoogle Scholar
  30. 30.
    Thornburg LP, Rottinghaus G, Dennis G, Crawford S (1996) The relationship between hepatic copper content and morphologic changes in the liver of West Highland White Terriers. Vet Pathology 33: 656–661Google Scholar
  31. 31.
    Thornburg LP, Rottinghaus G, Koch J, Hause WR (1983) High liver copper levels in Doberman Pinschers with subacute hepatitis. J Am Animal Hosp Assoc 20: 1003–1005Google Scholar
  32. 32.
    Thornburg LP, Shaw D, Dolan M, Raisbeck M, Crawford S, Dennis GL, Olwin DB (1986) Hereditary copper toxicosis in West Highland White terriers. Vet Pathology 23: 148–154Google Scholar
  33. 33.
    Webb CB, Twedt DC, Meyer DJ (2002) Copper-associated liver disease in Dalmatians: a review of 10 dogs (1998–2001). J Vet Internal Med 16: 665–668CrossRefGoogle Scholar
  34. 34.
    Forman OP, Boursnell ME, Dunmore BJ, Stendall N, van den Sluis B, Fretwell N, Jones C, Wijmenga C, Rothuizen J, van Oost BA et al (2005) Characterization of the COMMD1 (MURR1) mutation causing copper toxicosis in Bedlington terriers. Anim Genet 36: 497–501PubMedGoogle Scholar
  35. 35.
    Mandigers PJ, van den Ingh TS, Bode P, Rothuizen J (2005) Improvement in liver pathology after 4 months of D-penicillamine in 5 doberman pinschers with subclinical hepatitis. J Vet Intern Med 19: 40–43PubMedCrossRefGoogle Scholar
  36. 36.
    Spee B, Arends B, van den Ingh TS, Roskams T, Rothuizen J, Penning LC (2007) Major HGF-mediated regenerative pathways are similarly affected in human and canine cirrhosis. Comp Hepatol 31; 6: 8–14CrossRefGoogle Scholar
  37. 37.
    Spee B, Arends B, van den Ingh TS, Brinkhof B, Nederbragt H, Ijzer J, Roskams T, Penning LC, Rothuizen J (2006) Transforming growth factor beta-1 signalling in canine hepatic diseases: new models for human fibrotic liver pathologies. Liver Int 26: 716–725PubMedCrossRefGoogle Scholar
  38. 38.
    Spee B, Penning LC, van den Ingh TS, Arends B, IIzer J, van Sluijs FJ, Rothuizen J (2005) Regenerative and fibrotic pathways in canine hepatic portosystemic shunt and portal vein hypoplasia, new models for clinical hepatocyte growth factor treatment. Comp Hepatol 4: 7–17PubMedCrossRefGoogle Scholar
  39. 39.
    Ijzer J, Roskams T, Molenbeek RF, Ultee T, Penning LC, Rothuizen J, van den Ingh TS (2006) Morphological characterisation of portal myofibroblasts and hepatic stellate cells in the normal dog liver. Comp Hepatol 5: 7–13PubMedCrossRefGoogle Scholar

Copyright information

© Birkhäuser Verlag Basel/Switzerland 2008

Authors and Affiliations

  • Jan Rothuizen
    • 1
  1. 1.Department of Clinical Sciences of Companion Animals, Faculty of Veterinary MedicineUniversity UtrechtUtrechtThe Netherlands

Personalised recommendations